Original research ranges from new concepts in human biology and disease pathogenesis to new therapeutic modalities and drug development, to all phases of clinical work, as well as innovative ...
Our researchers work in various phases of drug discovery ... Many others are undergoing clinical trials in the United States and beyond. Clinical trials of drugs discovered or developed by Purdue ...
The U.S. observed prevalence of relapsed/refractory AL Amyloidosis is estimated to be growing at 12% per year according to Staron, et al Blood Cancer Journal, to approximately 33,277 patients in 2024.